Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Der Pathologe|January 20, 2006
[Hematological side effects of tyrosine kinase inhibition using imatinib]A Schmitt-Graeff, A Hochhaus
Leukemia & Lymphoma|July 12, 2003
Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patientsJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Histopathology|November 26, 2003
Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosisJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Der Pathologe|February 9, 2000
[Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis]A Schmitt-Graeff, D Mattern, H Köhler, et al.
Der Pathologe|February 9, 2000
[Prognostic factors and survival in chronic myeloproliferative disorders]H M Kvasnicka, J Thiele, A Schmitt-Graeff, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 16, 2007
CD117 (c-kit) expression in human hepatocellular carcinomaG Becker, A Schmitt-Graeff, V Ertelt, et al.
Pediatric Transplantation|February 16, 2007
Polymyositis--an unusual presentation of cGvHD in childrenR Klein, P Franck, S Ehl, et al.
Histopathology|September 30, 2000
Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemiaJ Thiele, H M Kvasnicka, A Schmitt-Graeff, et al.
Pageof 4